Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas. | JCI Insight | 2023 | 37870961 | PubTator, text mining | PubMed |
| Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology. | Medicine (Baltimore) | 2023 | 37861538 | PubTator, text mining | PubMed |
| Immune-related signature of periodontitis and Alzheimer's disease linkage. | Front Genet | 2023 | 37849501 | PubTator, text mining | PubMed |
| A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production. | Am J Physiol Lung Cell Mol Physiol | 2023 | 37847710 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia. | Genome Med | 2023 | 37845689 | PubTator, text mining | PubMed |
| Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review. | Front Pharmacol | 2023 | 37841935 | PubTator, text mining | PubMed |
| DKK1 Promotes Epithelial-Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway. | Cancers (Basel) | 2023 | 37835450 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| Isoform-specific optical activation of kinase function reveals p38-ERK signaling crosstalk. | RSC Chem Biol | 2023 | 37799579 | PubTator, text mining | PubMed |
| Are We Ready to Reclassify Crohn's Disease Using Molecular Classification? | J Clin Med | 2023 | 37762727 | PubTator, text mining | PubMed |
| Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines. | Biomedicines | 2023 | 37760847 | PubTator, text mining | PubMed |
| Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. | Nat Commun | 2023 | 37758692 | PubTator, text mining | PubMed |
| Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer. | J Funct Biomater | 2023 | 37754880 | PubTator, text mining | PubMed |
| Role of neutrophil extracellular trap and immune infiltration in atherosclerotic plaque instability: Novel insight from bioinformatics analysis and machine learning. | Medicine (Baltimore) | 2023 | 37747003 | PubTator, text mining | PubMed |
| Inflammation-related signaling pathways in tendinopathy. | Open Life Sci | 2023 | 37744452 | PubTator, text mining | PubMed |
| Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies. | Chromosome Res | 2023 | 37721639 | PubTator, text mining | PubMed |
| Analysis of the mechanism of action of Euphorbia fischeriana Steud on cirrhosis based on network pharmacology. | Medicine (Baltimore) | 2023 | 37713886 | PubTator, text mining | PubMed |
| Obesity associated cancers, genetics, epigenetics and elephants. | J Transl Genet Genom | 2023 | 37693940 | PubTator, text mining | PubMed |
| A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers. | Int J Mol Sci | 2023 | 37686122 | PubTator, text mining | PubMed |
| Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment. | Front Pharmacol | 2023 | 37680708 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=7